Sumitomo Pharma
We are united in our mission to advance scientific understanding and deliver meaningful and differentiated therapies that improve the lives of patients in areas of unique and unmet need across multiple therapeutic areas.
Rethymic
Allogeneic processed thymus tissue–agdc.
Approved to treat: Congenital athymia.
Report side effects/adverse reactions at 833-369-9868.

